BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Di Marco M, Grassi E, Durante S, Vecchiarelli S, Palloni A, Macchini M, Casadei R, Ricci C, Panzacchi R, Santini D, Biasco G. State of the art biological therapies in pancreatic cancer. World J Gastrointest Oncol 2016; 8(1): 55-66 [PMID: 26798437 DOI: 10.4251/wjgo.v8.i1.55]
URL: https://www.wjgnet.com/1948-5204/full/v8/i1/55.htm
Number Citing Articles
1
Nicola Silvestris, Oronzo Brunetti, Enrico Vasile, Francesco Cellini, Ivana Cataldo, Valeria Pusceddu, Monica Cattaneo, Stefano Partelli, Mario Scartozzi, Giuseppe Aprile, Andrea Casadei Gardini, Alessio Giuseppe Morganti, Vincenzo Valentini, Aldo Scarpa, Massimo Falconi, Angela Calabrese, Vito Lorusso, Michele Reni, Stefano Cascinu. Multimodal treatment of resectable pancreatic ductal adenocarcinomaCritical Reviews in Oncology/Hematology 2017; 111: 152 doi: 10.1016/j.critrevonc.2017.01.015
2
Xinjian Liu, Hao Yuan, Jing Zhou, Qiongling Wang, Xiaoqiang Qi, Catharine Bernal, Diego Avella, Jussuf T. Kaifi, Eric T. Kimchi, Parrett Timothy, Kun Cheng, Yi Miao, Kuirong Jiang, Guangfu Li. LMO7 as an Unrecognized Factor Promoting Pancreatic Cancer Progression and MetastasisFrontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.647387
3
Guo Chen, Haiyang Song, Zelong Yang, Tianshu Du, Yu Zheng, Zifan Lu, Kunpeng Zhang, Di Wei. AQP5 Is a Novel Prognostic Biomarker in Pancreatic AdenocarcinomaFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.890193
4
Eileen M. O’Reilly, Do-Youn Oh, Neesha Dhani, Daniel J. Renouf, Myung Ah Lee, Weijing Sun, George Fisher, Aram Hezel, Shao-Chun Chang, Gordana Vlahovic, Osamu Takahashi, Yin Yang, David Fitts, Philip Agop Philip. Durvalumab With or Without Tremelimumab for Patients With Metastatic Pancreatic Ductal AdenocarcinomaJAMA Oncology 2019; 5(10): 1431 doi: 10.1001/jamaoncol.2019.1588
5
Omer Hanif, Zhu Donghua, Wang Xuefeng, M. Saqib Nawaz. Refining the Measurement of Topic Similarities Through Bibliographic Coupling and LDAIEEE Access 2019; 7: 179997 doi: 10.1109/ACCESS.2019.2958489
6
Radim Moravec, Rao Divi, Mukesh Verma. Detecting circulating tumor material and digital pathology imaging during pancreatic cancer progressionWorld Journal of Gastrointestinal Oncology 2017; 9(6): 235-250 doi: 10.4251/wjgo.v9.i6.235
7
Yu-Ting Fang, Wen-Wei Yang, Ya-Ru Niu, Yong-Kun Sun. Recent advances in targeted therapy for pancreatic adenocarcinomaWorld Journal of Gastrointestinal Oncology 2023; 15(4): 571-595 doi: 10.4251/wjgo.v15.i4.571
8
JINGMEI LUO, LI YU, GUANGCHENG XIE, DAN LI, MENG SU, XUERONG ZHAO, LUANYING DU. Study on the mitochondrial apoptosis pathways of small cell lung cancer H446 cells induced by Trichinella spiralis muscle larvae ESPsParasitology 2017; 144(6): 793 doi: 10.1017/S0031182016002535
9
Steven N. Hochwald, William G. Cance, Elena Kurenova. Encyclopedia of Cancer2014; : 1 doi: 10.1007/978-3-642-27841-9_4358-4
10
Yong An, Xue-min Chen, Yong Yang, Feng Mo, Yong Jiang, Dong-lin Sun, Hui-hua Cai. LncRNA DLX6-AS1 promoted cancer cell proliferation and invasion by attenuating the endogenous function of miR-181b in pancreatic cancerCancer Cell International 2018; 18(1) doi: 10.1186/s12935-018-0643-7
11
Hadas Gibori, Shay Eliyahu, Adva Krivitsky, Dikla Ben-Shushan, Yana Epshtein, Galia Tiram, Rachel Blau, Paula Ofek, Joo Sang Lee, Eytan Ruppin, Limor Landsman, Iris Barshack, Talia Golan, Emmanuelle Merquiol, Galia Blum, Ronit Satchi-Fainaro. Amphiphilic nanocarrier-induced modulation of PLK1 and miR-34a leads to improved therapeutic response in pancreatic cancerNature Communications 2018; 9(1) doi: 10.1038/s41467-017-02283-9
12
Stefania Cannone, Maria Raffaella Greco, Tiago M. A. Carvalho, Helene Guizouarn, Olivier Soriani, Daria Di Molfetta, Richard Tomasini, Katrine Zeeberg, Stephan Joel Reshkin, Rosa Angela Cardone. Cancer Associated Fibroblast (CAF) Regulation of PDAC Parenchymal (CPC) and CSC Phenotypes Is Modulated by ECM CompositionCancers 2022; 14(15): 3737 doi: 10.3390/cancers14153737
13
M. Bupathi, D. H. Ahn, C. Wu, K. K. Ciombor, J. A. Stephens, J. Reardon, D. A. Goldstein, T. Bekaii-Saab. Modified irinotecan and infusional 5-fluorouracil (mFOLFIRI) in patients with refractory advanced pancreas cancer (APC): a single-institution experienceMedical Oncology 2016; 33(4) doi: 10.1007/s12032-016-0753-9
14
Matineh Barati Bagherabad, Fahimeh Afzaljavan, Soodabeh ShahidSales, Seyed Mahdi Hassanian, Amir Avan. Targeted therapies in pancreatic cancer: Promises and failuresJournal of Cellular Biochemistry 2019; 120(3): 2726 doi: 10.1002/jcb.26284
15
Steven N. Hochwald, William G. Cance, Elena Kurenova. Encyclopedia of Cancer2014; : 3421 doi: 10.1007/978-3-662-46875-3_4358
16
Douglas K. Brubaker, Joao A. Paulo, Shikha Sheth, Emily J. Poulin, Olesja Popow, Brian A. Joughin, Samantha Dale Strasser, Alina Starchenko, Steven P. Gygi, Douglas A. Lauffenburger, Kevin M. Haigis. Proteogenomic Network Analysis of Context-Specific KRAS Signaling in Mouse-to-Human Cross-Species TranslationCell Systems 2019; 9(3): 258 doi: 10.1016/j.cels.2019.07.006
17
Mohamed El-Tanani, Hamdi Nsairat, Ismail I. Matalka, Alaa A. A. Aljabali, Vijay Mishra, Yachana Mishra, Gowhar A. Naikoo, Sai Raghuveer Chava, Nitin B. Charbe, Murtaza M. Tambuwala. Impact of exosome therapy on pancreatic cancer and its progressionMedical Oncology 2023; 40(8) doi: 10.1007/s12032-023-02101-x
18
Catherine S. Wegner, Anette Hauge, Jon-Vidar Gaustad, Lise Mari K. Andersen, Trude G. Simonsen, Kanthi Galappathi, Einar K. Rofstad. Dynamic contrast-enhanced MRI of the microenvironment of pancreatic adenocarcinoma xenograftsActa Oncologica 2017; 56(12): 1754 doi: 10.1080/0284186X.2017.1343494
19
Alexandr V. Bazhin, Katharina von Ahn, Jasmin Fritz, Henriette Bunge, Caroline Maier, Orkhan Isayev, Florian Neff, Jens T. Siveke, Svetlana Karakhanova. Pivotal antitumor role of the immune checkpoint molecule B7-H1 in pancreatic cancerOncoImmunology 2022; 11(1) doi: 10.1080/2162402X.2022.2043037
20
Giuseppe Tridente. Adverse Events and Oncotargeted Kinase Inhibitors2017; : 145 doi: 10.1016/B978-0-12-809400-6.00007-X
21
Hongjuan Yao, Wenping Song, Rui Cao, Cheng Ye, Li Zhang, Hebing Chen, Junting Wang, Yuchen Shi, Rui Li, Yi Li, Xiujun Liu, Xiaofei Zhou, Rongguang Shao, Liang Li. An EGFR/HER2-targeted conjugate sensitizes gemcitabine-sensitive and resistant pancreatic cancer through different SMAD4-mediated mechanismsNature Communications 2022; 13(1) doi: 10.1038/s41467-022-33037-x
22
Nicole Lintern, Andrew M. Smith, David G. Jayne, Yazan S. Khaled. Photodynamic Stromal Depletion in Pancreatic Ductal AdenocarcinomaCancers 2023; 15(16): 4135 doi: 10.3390/cancers15164135
23
Indraneil Mukherjee, Brett Powell, Mary Parianos, Darrell Downs, Sharona B. Ross. Available technologies and clinical applications of targeted chemotherapy in pancreatic cancerCancer Genetics 2016; 209(12): 582 doi: 10.1016/j.cancergen.2016.08.001
24
Célia Cintas, Thibaut Douché, Nicole Therville, Silvia Arcucci, Fernanda Ramos-Delgado, Céline Basset, Benoît Thibault, Julie Guillermet-Guibert. Signal-Targeted Therapies and Resistance Mechanisms in Pancreatic Cancer: Future Developments Reside in ProteomicsCancers 2018; 10(6): 174 doi: 10.3390/cancers10060174
25
Giulia Biondani, Katrine Zeeberg, Maria Raffaella Greco, Stefania Cannone, Ilaria Dando, Elisa Dalla Pozza, Maria Mastrodonato, Stefania Forciniti, Valeria Casavola, Marta Palmieri, Stephan Joel Reshkin, Rosa Angela Cardone. Extracellular matrix composition modulates PDAC parenchymal and stem cell plasticity and behavior through the secretomeThe FEBS Journal 2018; 285(11): 2104 doi: 10.1111/febs.14471
26
Zilong Zhang, Jin Shang, Zonglin Dai, Yutong Yao, Ying Shi, Deyuan Zhong, Yuxin Liang, Chunyou Lai, Qinyan Yang, Tianhang Feng, Xiaolun Huang. Transmembrane Protein 170B is a Prognostic Biomarker and Associated With Immune Infiltrates in Pancreatic AdenocarcinomaFrontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.848391